Share

As part of MedTech Digital Week, Executive vice-president Oliver Christ and senior consultant of regulatory affairs and project management Berkin Guler at NSF’s PROSYSTEM discusses taking advantage of the EU ³Ô¹ÏºÚÁÏÍøs Regulation (MDR) post-market surveillance (PMS).